ROS contribute to tissue inflammation with increased levels of inflammatory mediators, including IL-6, C-reactive protein (CRP) and TNF, which are detected in both acute and chronic kidney disease and acute and chronic HF. This evidence concerns the gene CRP and chronic kidney disease.